GENENCOR INTERNATIONAL INC

Healthcare · In Vitro & In Vivo Diagnostic Substances · DE · SEC filings ↗ · Compare ⊕

Financials

SEC XBRL · annual

No structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).

Insider transactions

SEC Form 4 · most recent

1 acquisitions3 disposals1 open-market buy(s)net +8.6M shares · last 4

Insider	Date	Type	Shares	Price
Ranieri Richard JOfficer — Senior VP-Human Resources	Apr 20, 2005	U	7,000	$19.25
Danisco A/S /Fi10% owner	Apr 20, 2005	Buy	8.7M	$19.25
Pekich Thomas JOfficer — Group VP-Bioproducts	Apr 20, 2005	U	10,683	$19.25
Land Raymond JOfficer — Senior VP and CFO	Apr 20, 2005	U	12,151	$19.25

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

CT ORDERDec 21, 2010
CT ORDEROct 29, 2010
4PRIMARY DOCUMENTApr 22, 2005
4Apr 22, 2005
4PRIMARY DOCUMENTApr 22, 2005
4PRIMARY DOCUMENTApr 22, 2005
4PRIMARY DOCUMENTApr 22, 2005
4PRIMARY DOCUMENTApr 22, 2005
4PRIMARY DOCUMENTApr 22, 2005
4PRIMARY DOCUMENTApr 22, 2005
4PRIMARY DOCUMENTApr 22, 2005
4PRIMARY DOCUMENTApr 22, 2005
4PRIMARY DOCUMENTApr 22, 2005
4PRIMARY DOCUMENTApr 22, 2005
4PRIMARY DOCUMENTApr 22, 2005

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.